All Deals
December 8, 2025 - Deals
General Intelligence Company Raises $8.7 Million In Seed Funding Led By Union Square Ventures
The General Intelligence Company of New York has raised $8.7 million in seed funding led by Union Square Ventures, with participation from Acrew Capital, Compound, Scott Belsky, Yohei Nakajima, Agent Fund, Mute Ventures, basement.studio, John Phamous, Matthew Parkhurst, Sarah Chieng, Jacky Huang, and The House Fund. Founded by Andrew P., the company is building a full-stack AI agent platform designed to run entire business functions — positioning itself as core infrastructure for what it calls the future “one-person billion-dollar company.”
FOUNDERS: Andrew Pignanelli & Abhishyant Khare
INVESTORS: Union Square Ventures, Acrew Capital, Compound, Scott Belsky, Yohei Nakajima, Agent Fund, Mute Ventures, basement.studio, John Phamous, Matthew Parkhurst, Sarah Chieng, Jacky Huang & The House Found
ROUND: Seed
AMOUNT: $8,700,000
HQ: #NewYork #NY #NewYorkCity #NYC
#VentureCapital #TheGeneralIntelligenceCompanyofNewYork #UnionSquareVentures #AcrewCapital #Compound #ScottBelsky #YoheiNakajima #AgentFund #MuteVentures #basementstudio #JohnPhamous #MatthewParkhurst #SarahChieng #JackyHuang #TheHouseFund #TradedVC
More Deals
View All
AIP MGX BlackRock Acquire Aligned Data Centers For $40 BillionThe Artificial Intelligence Infrastructure Partnership (AIP), MGX, and BlackRock’s Global Infrastructure Partners have finalized their $40 billion acquisition of Aligned Data Centers from Macquarie Asset Management, setting a new record for the largest data center deal ever completed. The consortium has also pledged an additional $5 billion in growth funding to expand Aligned’s AI-ready data center footprint across North and South America. Aligned will continue to operate from its Dallas headquarters under the leadership of CEO Andrew Schaap and the current management team as the company scales its infrastructure to meet rapidly growing demand for AI and cloud computing capacity.
SALE PRICE: $40,000,000,000
#VentureCapital #ArtificialIntelligenceInfrastructurePartnership #MGX #GlobalInfrastructurePartners #TradedVC
Eli Lilly Acquires AtaiBeckley For Up To $3.8 Billion In Psychedelic Medicine DealEli Lilly is making its biggest move yet into psychedelic medicine through its planned acquisition of AtaiBeckley in a deal valued at up to $3.8 billion, the largest acquisition in the sector to date. The transaction centers on AtaiBeckley’s lead program, BPL-003, an intranasal 5-MeO-DMT therapy for treatment-resistant depression that is advancing into Phase 3 trials, along with a second DMT-based candidate in development. Founder Christian Angermayer said the focus is now on getting these therapies “into the hands of millions of patients around the globe as quickly as possible.” The deal reflects growing investor and pharmaceutical interest in psychedelic-based mental health treatments, following recent acquisitions by AbbVie and Otsuka as clinical evidence and policy support continue to strengthen across the field.
SALE PRICE: $3,800,000,000
#VentureCapital #EliLilly #AtaiBeckley #TradedVC